BDNF stimulates the non-amyloidogenic pathway of APP as a protective factor for AD, but OS leads to decreased BDNF levels and, in turn, leads to increased Aβ, which worsens AD progression99,100. This evidence concerns the gene BDNF and Alzheimer disease.